Novonesis (Novozymes A/S)
19.8.2026 17:39:40 CEST | Globenewswire | Press release
Increased outlook for 2026
Increased outlook for 2026
Novonesis increases its full year 2026 organic sales growth outlook from 5-7% to now 7-8% based on a stronger performance so far in the year and the expectations for the rest of the year. Following the stronger sales growth outlook, the adjusted EBITDA margin is now expected to be at the higher end of the 37-38% range.
The H1 2026 announcement will be announced on August 19, 2026.
Publication of inside information pursuant to Market Abuse Regulation, Article 17.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sika AG19.8.2026 20:01:06 CEST | Press release
SIKA SUCCESSFULLY PLACES EUR 1 BILLION HYBRID CAPITAL BOND
Grønlandsbanken A/S19.8.2026 19:56:28 CEST | Press release
The BANK of Greenland’s report for the first half of 2026
Grønlandsbanken A/S19.8.2026 19:56:28 CEST | Pressemeddelelse
GrønlandsBANKENs rapport for første halvår 2026
Seyond Inc19.8.2026 19:13:18 CEST | Press release
AMSYS and SEYOND Announce Strategic Partnership to Advance Spatial Intelligence and Operational Digital Twins
GN Store Nord A/S19.8.2026 18:55:00 CEST | Press release
Interim Report Q2 2026: Successful reception of Evolve3 headsets and gross margin improvement boding well for strong H2 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom